扩大在普通医学单位住院时的合作药剂师药物图表模型-开始使用新药物

IF 1 Q4 PHARMACOLOGY & PHARMACY
Phuong U. Hua BPharm(Hons), Gail Edwards BPharm, MClinPharm, Eleanor Van Dyk BPharm, MClinPharm, Gary Yip MBBS, FRACP, Biswadev Mitra MBBS, MHSM, PhD, FACEM, Michael J. Dooley BPharm, GradDipHospPharm, PhD, FISOPP, FSHPA, FAAQHC, Erica Y. Tong BPharm(Hons), MClinPharm, PhD
{"title":"扩大在普通医学单位住院时的合作药剂师药物图表模型-开始使用新药物","authors":"Phuong U. Hua BPharm(Hons),&nbsp;Gail Edwards BPharm, MClinPharm,&nbsp;Eleanor Van Dyk BPharm, MClinPharm,&nbsp;Gary Yip MBBS, FRACP,&nbsp;Biswadev Mitra MBBS, MHSM, PhD, FACEM,&nbsp;Michael J. Dooley BPharm, GradDipHospPharm, PhD, FISOPP, FSHPA, FAAQHC,&nbsp;Erica Y. Tong BPharm(Hons), MClinPharm, PhD","doi":"10.1002/jppr.1842","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Background</h3>\n \n <p>Increasing life expectancy has seen a continual rise in older patients who present to hospital with acute decompensation. Pharmacists are well equipped to make medication recommendations in these settings to meet patient care needs, promote harm minimisation, and improve workflow efficiency. The Partnered Pharmacist Medication Charting (PPMC) model enables pharmacists to chart regular medications for patients admitted to the General Medicine Unit (GMU) in collaboration with treating clinicians. The model was expanded to assess the safety of pharmacists additionally charting newly initiated medications.</p>\n </section>\n \n <section>\n \n <h3> Aim</h3>\n \n <p>The aim of this study was to assess the safety of the expanded PPMC model through the number of medication errors.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>This prospective observational study was conducted at a tertiary hospital. Patients admitted to the GMU and received PPMC were included. Pharmacists were able to chart any new medications as well as the patients' pre-admission medications. The primary outcome was the number of medication errors charted on admission. Medication errors were defined as medications charted outside of the specific recommendations documented in the medication management plan written by the PPMC pharmacist and co-signed by the admitting medical officer.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 8093 medications were charted by a credentialed pharmacist, with 10% (<i>n</i> = 816) planned newly initiated medications. Eight (0.98%) medication charting errors were identified in the PPMC model, which included five planned medications omitted. Of the 811 newly charted medications, 87 (10.7%) were amended within 24 h, with the majority being due to change in diagnosis or driven by changes in clinical status or investigative results becoming available.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>The expansion of the PPMC model of care to enable pharmacist charting of new medications was found to be safe. The adoption of the model may aid in reducing medication errors, thereby improving patient care and safety.</p>\n </section>\n </div>","PeriodicalId":16795,"journal":{"name":"Journal of Pharmacy Practice and Research","volume":null,"pages":null},"PeriodicalIF":1.0000,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Expansion of the partnered pharmacist medication charting model on admission in the General Medicine Unit — initiation of new medications\",\"authors\":\"Phuong U. Hua BPharm(Hons),&nbsp;Gail Edwards BPharm, MClinPharm,&nbsp;Eleanor Van Dyk BPharm, MClinPharm,&nbsp;Gary Yip MBBS, FRACP,&nbsp;Biswadev Mitra MBBS, MHSM, PhD, FACEM,&nbsp;Michael J. Dooley BPharm, GradDipHospPharm, PhD, FISOPP, FSHPA, FAAQHC,&nbsp;Erica Y. Tong BPharm(Hons), MClinPharm, PhD\",\"doi\":\"10.1002/jppr.1842\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Background</h3>\\n \\n <p>Increasing life expectancy has seen a continual rise in older patients who present to hospital with acute decompensation. Pharmacists are well equipped to make medication recommendations in these settings to meet patient care needs, promote harm minimisation, and improve workflow efficiency. The Partnered Pharmacist Medication Charting (PPMC) model enables pharmacists to chart regular medications for patients admitted to the General Medicine Unit (GMU) in collaboration with treating clinicians. The model was expanded to assess the safety of pharmacists additionally charting newly initiated medications.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Aim</h3>\\n \\n <p>The aim of this study was to assess the safety of the expanded PPMC model through the number of medication errors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>This prospective observational study was conducted at a tertiary hospital. Patients admitted to the GMU and received PPMC were included. Pharmacists were able to chart any new medications as well as the patients' pre-admission medications. The primary outcome was the number of medication errors charted on admission. Medication errors were defined as medications charted outside of the specific recommendations documented in the medication management plan written by the PPMC pharmacist and co-signed by the admitting medical officer.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 8093 medications were charted by a credentialed pharmacist, with 10% (<i>n</i> = 816) planned newly initiated medications. Eight (0.98%) medication charting errors were identified in the PPMC model, which included five planned medications omitted. Of the 811 newly charted medications, 87 (10.7%) were amended within 24 h, with the majority being due to change in diagnosis or driven by changes in clinical status or investigative results becoming available.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>The expansion of the PPMC model of care to enable pharmacist charting of new medications was found to be safe. The adoption of the model may aid in reducing medication errors, thereby improving patient care and safety.</p>\\n </section>\\n </div>\",\"PeriodicalId\":16795,\"journal\":{\"name\":\"Journal of Pharmacy Practice and Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2022-11-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacy Practice and Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1842\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacy Practice and Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/jppr.1842","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

摘要

随着预期寿命的延长,因急性代偿失代偿而住院的老年患者不断增加。药剂师有能力在这些环境中提出药物建议,以满足患者护理需求,促进危害最小化,并提高工作流程效率。合作药剂师药物图表(PPMC)模式使药剂师能够与治疗临床医生合作,为普通医学单位(GMU)收治的患者绘制常规药物图表。该模型被扩展到评估药剂师的安全性,并绘制新启动药物的图表。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Expansion of the partnered pharmacist medication charting model on admission in the General Medicine Unit — initiation of new medications

Background

Increasing life expectancy has seen a continual rise in older patients who present to hospital with acute decompensation. Pharmacists are well equipped to make medication recommendations in these settings to meet patient care needs, promote harm minimisation, and improve workflow efficiency. The Partnered Pharmacist Medication Charting (PPMC) model enables pharmacists to chart regular medications for patients admitted to the General Medicine Unit (GMU) in collaboration with treating clinicians. The model was expanded to assess the safety of pharmacists additionally charting newly initiated medications.

Aim

The aim of this study was to assess the safety of the expanded PPMC model through the number of medication errors.

Method

This prospective observational study was conducted at a tertiary hospital. Patients admitted to the GMU and received PPMC were included. Pharmacists were able to chart any new medications as well as the patients' pre-admission medications. The primary outcome was the number of medication errors charted on admission. Medication errors were defined as medications charted outside of the specific recommendations documented in the medication management plan written by the PPMC pharmacist and co-signed by the admitting medical officer.

Results

A total of 8093 medications were charted by a credentialed pharmacist, with 10% (n = 816) planned newly initiated medications. Eight (0.98%) medication charting errors were identified in the PPMC model, which included five planned medications omitted. Of the 811 newly charted medications, 87 (10.7%) were amended within 24 h, with the majority being due to change in diagnosis or driven by changes in clinical status or investigative results becoming available.

Conclusion

The expansion of the PPMC model of care to enable pharmacist charting of new medications was found to be safe. The adoption of the model may aid in reducing medication errors, thereby improving patient care and safety.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Pharmacy Practice and Research
Journal of Pharmacy Practice and Research Health Professions-Pharmacy
CiteScore
1.60
自引率
9.50%
发文量
68
期刊介绍: The purpose of this document is to describe the structure, function and operations of the Journal of Pharmacy Practice and Research, the official journal of the Society of Hospital Pharmacists of Australia (SHPA). It is owned, published by and copyrighted to SHPA. However, the Journal is to some extent unique within SHPA in that it ‘…has complete editorial freedom in terms of content and is not under the direction of the Society or its Council in such matters…’. This statement, originally based on a Role Statement for the Editor-in-Chief 1993, is also based on the definition of ‘editorial independence’ from the World Association of Medical Editors and adopted by the International Committee of Medical Journal Editors.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信